Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Aug;20(4):260-264.
doi: 10.7181/acfs.2019.00283. Epub 2019 Aug 20.

A case of malignant melanoma after repeated recurrent dysplastic nevi

Affiliations
Case Reports

A case of malignant melanoma after repeated recurrent dysplastic nevi

Dae Kyun Jeong et al. Arch Craniofac Surg. 2019 Aug.

Abstract

Dysplastic nevus is common and affects about 10% of the northern European-descendent population. Studies over the past several decades have identified dysplastic nevi as a risk factor for malignant melanoma. Furthermore, in rare cases, they confirmed that dysplastic nevi have progressed to melanoma. Cases in which dysplastic nevi progressed to malignant melanoma in multiple studies are not uncommon. A 35-year-old woman presented with the major symptom of multiple itchy brown nodules (2.0 cm× 1.3 cm) in the left cheek that had first appeared 20 years earlier. Complete excision was performed at the first visit; subsequent biopsy confirmed that they were dysplastic nevi. They recurred three times over 3 years at the same site, all of which were histologically diagnosed as dysplastic nevi. Five years after the final excision, a brownish nodule developed in the left cheek, with others at the left temporal region, right retroauricular region, and left shoulder at the same time. These lesions were histologically diagnosed as malignant melanoma. We experienced a case of malignant melanoma that occurred at the same site after three recurrences of dysplastic nevi. Although rare, the possibility of malignant melanoma should be considered in follow-ups in cases involving repeatedly recurrent dysplastic nevi.

Keywords: Dysplastic nevus syndrome; Melanoma; Recurrence.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
Multiple itchy brownish nodules. Multiple itchy brownish nodules (2.0 cm×1.3 cm) in the left cheek that had first appeared 20 years prior.
Fig. 2.
Fig. 2.
First recurrence. A 0.5 cm×0.5 cm nodule that developed 15 months after the first excision.
Fig. 3.
Fig. 3.
Second recurrence. A 1.0 cm×0.5 cm nodule that developed 10 months after the second excision.
Fig. 4.
Fig. 4.
Third recurrence. A 0.5 cm nodule that developed 9 months after the third excision.
Fig. 5.
Fig. 5.
Histopathologic findings of recurrent dysplastic nevus (third recurrence). Melanocytes: round, regular cells with moderate amounts of cytoplasm. No nuclear atypia, pleiomorphism, or mitosis are visible (H&E, ×400).
Fig. 6.
Fig. 6.
Mass after three times of recurrence of dysplastic nevi. Mass in the left shoulder, left cheek, and right retroauricular region that developed 5 years and 9 months after the fourth excision, respectively. (A) Left cheek and (B) left shoulder.
Fig. 7.
Fig. 7.
Histopathologic findings of malignant melanoma after repeated recurrent dysplastic nevi. Tumor cell: round to oval nuclei showing mild nuclear pleomorphism with small nucleoli and irregular nuclear membrane. The cytoplasm contains melanin pigmentation. No mitosis is evident (H&E, ×400).

Similar articles

Cited by

References

    1. Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am. 2009;23:383–95. - PMC - PubMed
    1. Carey WP, Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer. 1994;74:3118–25. - PubMed
    1. Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, MacKie RM. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol. 1999;135:261–5. - PubMed
    1. Masri GD, Clark WH, Jr, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990;22(6 Pt 1):1042–8. - PubMed
    1. Weinstock MA, Barnhill RL, Rhodes AR, Brodsky GL. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel Arch Dermatol. 1997;133:953–8. - PubMed

Publication types

LinkOut - more resources